TY  - CONF

T1  - Extended adjuvant bisphosphonate treatment over five years in early breast cancer does not improve disease-free and overall survival compared to two years of treatment: Phase III data from the SUCCESS A study

JO  - CANCER RESEARCH

PY  - 2018/02/01

AU  - Janni W

AU  - Friedl TWP

AU  - Fehm T

AU  - Mueller V

AU  - Lichtenegger W

AU  - Blohmer J

AU  - Lorenz R

AU  - Forstbauer H

AU  - Bauer E

AU  - Fink V

AU  - Bekes I et al

ED  - 

VL  - 78

IS  - 4

Y2  - 2025/10/10

ER  -